Introduction: Followup care after an emergency department visit for kidney stones may help reduce emergency department revisits and increase use of stone prevention strategies. To test these hypotheses we analyzed medical claims from working age adults with kidney stones.
The emergency department serves as the initial entry point into the health care system for many patients with kidney stones. In fact, more than 1 million ED visits are made each year for the management of renal colic. 1 After pain relief is achieved and any associated complications necessitating surgical intervention are ruled out, most of these patients are discharged home with recommendations on primary care or urological followup. The twofold purpose of such followup is 1) to hasten short-term recovery and 2) to prevent long-term recurrence.
Despite the importance of timely followup, there are reasons to believe that compliance may be low. To begin with, a large proportion of patients will pass their stones spontaneously. 2, 3 Even among those who do not, their stone related symptoms may be self-limited. Indeed, less than half of patients with other chronic medical conditions who experience an acute exacerbation requiring an ED visit attend followup appointments. 4e7 Noncompliance in the stone population could have downstream consequences, including ED revisit and lower use of secondary prevention.
In this context we examined medical claims data from working age adults with ED visits for kidney stones. We then measured the frequency with which these patients had outpatient followup care for their stone disease. Finally, we examined associations between the receipt of followup care and ED revisit as well as use of stone prevention strategies. Our findings serve to inform the design of strategies for patient followup after an episode of renal colic that may improve clinical outcomes and decrease recurrence rates.
Methods

Data Source and Study Population
We used the Truven Health Analytics MarketScan Commercial Claims and Encounters database (2003 to 2006) . This database contains complete medical claims information regarding inpatient, outpatient and pharmacy services use from more than 17 million workers and their dependents with employer sponsored health insurance.
To begin, we used an established ICD-9 diagnosis code based algorithm to identify adults 18 to 64 years old with an initial ED visit for kidney stones. To measure subsequent ED revisits and the use of secondary prevention for kidney stones, we required continuous enrollment in a health benefit plan for 180 days after the index visit. For purposes of risk adjustment, subjects also needed to have coverage for a minimum of 365 days preceding their index ED visit. We made no exclusions based on a patient's prescription fill history. 
Primary Outcomes
We measured the frequency of ED revisits as well as the use of stone prevention strategies among the participants. A person was said to have a revisit if there was another ED encounter for stones between 90 and 180 days after the index claim. We defined use of stone prevention strategies by laboratory claims for 24-hour urine collection or prescription fills for PPT agents (based on National Drug Codes for thiazide diuretics, alkali citrate therapy or allopurinol) during the same claims window. 8 
Statistical Analysis
For our first analytic step we compared subjects who received post-ED followup care and those who did not. Specifically, we made bivariate comparisons, using t-tests and chi-square tests where appropriate, over a variety of sociodemographic characteristics including age, gender, employment status (salaried vs nonsalaried), urbanicity, benefit plan type (comprehensive plan, health maintenance organization, point of service, preferred provider organization or other noncapitated) and region of residence (East, West, South and Midwest). We also evaluated differences in the level of comorbid illness between these subjects using a composite measure.
We then examined associations between the receipt of followup care and ED revisit as well as the use of stone prevention strategies. To account for measured differences we fit multivariable logistic regression models including the characteristics previously described as covariates. Given the concern for confounding by disease severity we also controlled for whether a given subject underwent surgery, was hospitalized or had another ED encounter for kidney stones within the first 90 days of her/his index visit. We calculated robust standard errors using the Huber-White sandwich estimator.
We performed all analyses using SASÒ (version 9.3). All statistical tests were 2-sided with a type I error rate set at 0.05.
Our study received local institutional review board approval (IRB No. HUM00089056).
Results
During the study period we identified 70,294 patients with an ED visit for kidney stones. Less than half (48.0%) of the patients received outpatient followup care within 90 days of the index visit. Only two-thirds of the patients (68.3%) who did have followup care were seen by a urologist. Table 1 displays differences between patients with and without followup care. Younger patients (p <0.001), those with nonsalaried employment (p <0.001) and those who lived in a rural area (p <0.001) were less likely to receive followup care.
Overall 1,428 patients (2.0%) had an ED revisit within 90 to 180 days of the index visit. While the frequency of ED revisits did not differ between patients with and without followup care (2.1% vs 2.0%, p¼0.672), those with followup care were more likely to undergo 24-hour urine testing (2.7% vs 0.9%, p <0.001) and be prescribed a PPT agent (12.7% vs 10.3%, p <0.001). After controlling for important sociodemographic and disease severity differences, patients who received followup care were more likely to undergo 24-hour urine testing (predicted probability 2.2% vs 0.9%, p <0.001) and be prescribed PPT (predicted probability 10.6% vs 8.9%, p <0.001) compared to those who did not receive followup care. Among patients who received followup care the use of stone prevention strategies was higher when the care was delivered by a urologist (predicted probability 13.7% vs 12.3%, p¼0.001).
In other words, patients who received followup care had 2.5 times higher odds of undergoing 24-hour urine testing than those without followup care (table 2) . In addition, they had 22% higher odds of being prescribed a PPT agent. Compared to patients who received followup care from a nonurologist, those seen by a urologist had higher odds of 24-hour urine testing (OR 1.28, 95% CI 1.08e1.50) and being prescribed a PPT agent (OR 1.10, 95% CI 1.02e1.18).
Discussion
We evaluated the frequency of post-ED followup care during an acute stone episode. Less than half of patients seen in the ED for acute renal colic had a timely ambulatory visit after discharge home. The lack of followup care has downstream consequences for patients, as those without it were less likely to undergo 24-hour urine testing and be prescribed PPT. Whom patients see in followup is also important, as those patients with visits to a urologist were most likely to receive stone prevention strategies. Collectively these findings suggest opportunities for improving urinary stone disease care.
The literature on ED followup trends for kidney stones is sparse. A report from Sterrett et al showed that more than 80% of patients seen in their institution's ED during a 2-year period for ureteral stone disease had appropriate outpatient followup. 9 However, their findings, based on the experience of a single tertiary care center, may not be generalizable. The much lower rate of followup care that we observed among a much larger population of adults is consistent with studies on other patients with chronic medical conditions (eg chronic obstructive pulmonary disease, congestive heart failure, diabetes) demonstrating poor compliance with followup recommendations after ED discharge.
4e6,10 Our study must be considered in the context of several limitations. Lack of followup care after an ED encounter for kidney stones may be due to provider or patient factors. For example, an emergency medicine physician may not explicitly recommend followup care in the discharge instructions, or if such a recommendation is made, a patient may choose to not comply with it. Since we cannot determine with medical claims data whether a patient was given followup recommendations, we are unable to assess the contribution of provider nonfeasance (vs patient noncompliance) to the low rates of followup. The MarketScan database contains information about working age adults and their dependents with employer sponsored insurance. Thus, our results may not be extrapolated to elderly patients or patients with government sponsored insurance such as Medicaid or Medicare. Regardless, our cohort is representative of the population among whom the prevalence of kidney stones is highest. Moreover, MarketScan data lack granular clinical information (eg stone size and number) that could influence patient followup. However, to account for possible differences in disease severity we controlled for subsequent ED revisit, hospitalization or stone directed surgery within 90 to 180 days of the index visit. Furthermore, while we know whether patients filled a prescription for a PPT agent and whether they completed a 24-hour urine collection, we cannot discern from medical claims data whether a PPT agent was prescribed but never filled, nor can we assess whether a 24-hour urine collection was ordered by a provider but never completed by the patient. As such, we likely underestimate the frequency with which stone prevention strategies are being recommended. Finally, we acknowledge that our primary measure, the use of stone prevention strategies, is an intermediate outcome, and future studies are needed to examine how receipt of followup care relates to symptomatic stone recurrence.
Despite these limitations our findings have important implications for patients and our health care system. Low followup rates correspond with lower use of stone prevention strategies, which may ultimately lead to increased rates of stone recurrence. With nearly half of patients experiencing a symptomatic stone event within 10 Specifically, our data highlight the need to improve linkages between the ED and outpatient clinics, helping ensure urological followup. A variety of modalities could be used to improve followup rates. Recent analyses have demonstrated improved patient followup with automated appointment reminders via telephone or texting. 16, 17 With the growing use of electronic health records, followup could also be improved with patient portal messages or direct communication between ED providers and outpatient clinics through health information exchanges.
Conclusions
Nearly half of the patients in our study who were seen acutely in the ED for kidney stones did not receive followup care. Given that followup was associated with greater use of secondary stone prevention, there is an urgent need to examine trends in post-ED stone care using more contemporary data. Insofar as rates of followup remain low, efforts to enhance linkages across settings may be needed to provide patients with more comprehensive care.
